Skip to main content
. 2016 Jun 22;12(2):1373–1379. doi: 10.3892/ol.2016.4764

Table I.

Association of TRPM8 expression with clinicopathological features of osteosarcoma.

TRPM8

Features Cases, n Positive, n (%) Negative, n (%) P-valuea
Age at diagnosis 0.481
  <18 years 47 30 (63.8) 17 (36.2)
  ≥18 years 51 29 (56.9) 22 (43.1)
Gender 0.905
  Female 42 25 (59.5) 17 (40.5)
  Male 56 34 (60.7) 22 (39.3)
Histological subtype 0.207
  Osteoblastic 44 22 (50.0) 22 (50.0)
  Chondroblastic 20 15 (75.0)   5 (25.0)
  Fibroblastic 14   9 (64.3)   5 (35.7)
  Mixed 20 14 (70.0)   6 (30.0)
Clinical stage 0.007
  I+IIA 62 31 (50.0) 31 (50.0)
  IIB/III 36 28 (77.8)   8 (22.2)
Distant metastasis 0.030
  Absent 60 31 (51.7) 29 (48.3)
  Present 38 28 (73.7) 10 (26.3)
Tumor size 0.429
  <5 cm 53 30 (56.6) 23 (43.4)
  ≥5 cm 45 29 (64.4) 16 (35.6)
Anatomic location 0.369
  Tibia/femur 60 34 (56.7) 26 (43.3)
  Elsewhere 38 25 (65.8) 13 (34.2)
a

P-value obtained from Pearson χ2 test or Fisher's exact test. TRPM8, transient receptor potential melastatin member 8.